AU2001280234A1 - Myricetin as an inhibitor of serotonin n-acetyltransferase - Google Patents

Myricetin as an inhibitor of serotonin n-acetyltransferase

Info

Publication number
AU2001280234A1
AU2001280234A1 AU2001280234A AU8023401A AU2001280234A1 AU 2001280234 A1 AU2001280234 A1 AU 2001280234A1 AU 2001280234 A AU2001280234 A AU 2001280234A AU 8023401 A AU8023401 A AU 8023401A AU 2001280234 A1 AU2001280234 A1 AU 2001280234A1
Authority
AU
Australia
Prior art keywords
myricetin
acetyltransferase
serotonin
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001280234A
Inventor
Bo-Hwa Choi
Kyong-Tai Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEURONEX CO Ltd
Original Assignee
NEURONEX CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEURONEX CO Ltd filed Critical NEURONEX CO Ltd
Publication of AU2001280234A1 publication Critical patent/AU2001280234A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AU2001280234A 2000-08-22 2001-08-22 Myricetin as an inhibitor of serotonin n-acetyltransferase Abandoned AU2001280234A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR10-2000-0048772A KR100407399B1 (en) 2000-08-22 2000-08-22 Use of myricetin as an inhibitor for serotonin N-acetyltransferase
KR0048772 2000-08-22
PCT/KR2001/001416 WO2002015901A1 (en) 2000-08-22 2001-08-22 Myricetin as an inhibitor of serotonin n-acetyltransferase

Publications (1)

Publication Number Publication Date
AU2001280234A1 true AU2001280234A1 (en) 2002-03-04

Family

ID=19684577

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001280234A Abandoned AU2001280234A1 (en) 2000-08-22 2001-08-22 Myricetin as an inhibitor of serotonin n-acetyltransferase

Country Status (3)

Country Link
KR (1) KR100407399B1 (en)
AU (1) AU2001280234A1 (en)
WO (1) WO2002015901A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100407399B1 (en) * 2000-08-22 2003-11-28 주식회사 뉴로넥스 Use of myricetin as an inhibitor for serotonin N-acetyltransferase
BR0204228A (en) * 2001-02-20 2004-06-22 Randy Ziegler Methods to improve the symptoms of a psychosis and schizophrenia and to screen test molecules, and, organic compound.
EP1750808B1 (en) * 2004-05-18 2011-02-09 Bright Future Pharmaceutical Laboratories Limited Myricitrin compounds for treating sleeping disorders
CN100337661C (en) * 2004-06-04 2007-09-19 澳美制药厂有限公司 Application of ampelopsis plant and its extract in preparing medicine and health article
CA2595486A1 (en) * 2005-01-20 2006-07-27 Sirtris Pharmaceuticals, Inc. Use of sirtuin-activating compounds for treating flushing and drug induced weight gain
KR101454425B1 (en) 2012-10-11 2014-11-03 포항공과대학교 산학협력단 Composition for exercise performance improvement comprising myricetin as active ingredient
CN104127404A (en) * 2014-07-08 2014-11-05 华侨大学 Anti-depression drug and preparation method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19646977A1 (en) * 1995-09-29 1998-01-15 Schwabe Willmar Gmbh & Co Stable dry extract of Hypericum perforatum L., Saint John's wort
EP1094825A2 (en) * 1997-10-23 2001-05-02 Pharmaprint, Inc. Pharmaceutical grade st. john's wort
KR100407399B1 (en) * 2000-08-22 2003-11-28 주식회사 뉴로넥스 Use of myricetin as an inhibitor for serotonin N-acetyltransferase

Also Published As

Publication number Publication date
WO2002015901A1 (en) 2002-02-28
KR100407399B1 (en) 2003-11-28
KR20020015609A (en) 2002-02-28

Similar Documents

Publication Publication Date Title
PT1749818E (en) Phenyl-piperidine derivatives as serotonin reuptake inhibitors
AU2002333524A1 (en) Furo-and thienopyrimidine derivatives as angiogenesis inhibitors
AU2001269939A1 (en) Methods for eliminating the formation of biofilm
AU2002305205A1 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
AU2002344567A1 (en) Heterocyclic amide compounds as apolipoprotein b inhibitors
AU2003282891A1 (en) Novel tyrosine kinases inhibitors
AU2001274009A1 (en) Substituted indoles as parp inhibitors
AU2002333233A1 (en) Interaction inhibitors of tcf-4 with beta-catenin
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
PL364580A1 (en) Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
AU2001235997A1 (en) Fluorescent probes for the quantitation of zinc
AU2001278980A1 (en) Coumarin derivatives useful as tnfalpha inhibitors
AU2002357003A1 (en) Indoles as naaladase inhibitors
AU2002326949A1 (en) Method for the inhibition of methanogenesis
AU2002222627A1 (en) Tak1 inhibitors
AU2001280234A1 (en) Myricetin as an inhibitor of serotonin n-acetyltransferase
AU2002306734A1 (en) Inhibitors of plasmepsins
AU2002241211A1 (en) Imidazo-triazine derivatives as pde 5 inhibitors
AU2002224550A1 (en) Corrosion inhibitors
AU2002214038A1 (en) Inhibitors of transglutaminases
PL371427A1 (en) New uses of substituted aminoalkanephosphonic acids
AU2002328894A1 (en) Substituted 4-aminocyclohexanol derivatives
AU2003288623A1 (en) Method of measuring the performance of an illumination system
AU2003230030A1 (en) Acyl bicyclix derivatives of pyrrol
AU2003242559A1 (en) Alkylaminosiloxanes as corrosion inhibitors